GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aethlon Medical Inc (FRA:EJU0) » Definitions » Float Percentage Of Total Shares Outstanding

Aethlon Medical (FRA:EJU0) Float Percentage Of Total Shares Outstanding : 51.16% (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aethlon Medical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aethlon Medical's float shares is 2.60 Mil. Aethlon Medical's total shares outstanding is 5.08 Mil. Aethlon Medical's float percentage of total shares outstanding is 51.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aethlon Medical's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aethlon Medical's Institutional Ownership is 1.52%.


Aethlon Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Aethlon Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.60/5.08
=51.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aethlon Medical (FRA:EJU0) Business Description

Industry
Traded in Other Exchanges
Address
11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical (FRA:EJU0) Headlines

No Headlines